Sansure Biotech

Sansure Biotech EBIT per Share

The EBIT per Share of Sansure Biotech (688289.SS) as of Oct 27, 2026 is 0.34 CNY. In the previous year, EBIT per Share was 0.45 CNY — a change of -23.52% (lower).

EBIT per Share

0.34CNY

YoY

-23.52%

Last updated:

EBIT per Share of Sansure Biotech is 2025 0.34 CNY. EBIT per Share of Sansure Biotech was 2024 0.45 CNY. It decreases by -23.52% lower compared to the previous year.

The Sansure Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
4.43 CNY
Jan 1, 2022
3.96 CNY
Jan 1, 2023
0.73 CNY
Jan 1, 2024
0.45 CNY
Jan 1, 2025
0.34 CNY
Jan 1, 2026 (e)
0.44 CNY
Jan 1, 2027 (e)
0.51 CNY
Jan 1, 2028 (e)
0.58 CNY
The Sansure Biotech EBIT per Share history
YEAREBIT per ShareYoY
est0.58CNY+13.50%
est0.51CNY+15.14%
est0.44CNY+28.73%
0.34CNY-23.52%
0.45CNY-38.95%
0.73CNY-81.51%
3.96CNY-10.60%
4.43CNY-15.16%
5.22CNY+10,274.05%
0.05CNY+154.68%
0.02CNY-142.21%
-0.05CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sansure Biotech Stock analysis

What does Sansure Biotech do? Sansure Biotech, Inc. generates revenue through the research, development, production, and sales of diagnostic reagents and instruments. Its diagnostic reagent portfolio includes the viral hepatitis series, reproductive tract infection and genetic series, pediatric infection series, and nucleic acid blood screening series. The company also offers instrument products such as the automatic nucleic acid detection reaction system construction series and fluorescent polymerase chain reaction monitoring and analysis software. The firm extends its business model by providing related inspection services, specifically medical inspection and scientific research services, which are delivered to medical institutions. This combination of product sales and service provision allows Sansure Biotech, Inc. to serve the healthcare and research sectors with its comprehensive diagnostic solutions. Sansure Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sansure Biotech stock

EBIT per Share of Sansure Biotech is 0.34 CNY in 2025.

EBIT per Share of Sansure Biotech changed from 0.45 CNY to 0.34 CNY, representing a -23.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Sansure Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sansure Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sansure Biotech